top of page

She Blinded Me with Science!!! Part XIV: The Promising Horizon of Autologous Treatments for Back Pain

Writer: Deborah Westergaard, M.D.
Deborah Westergaard, M.D.
Feb 22, 2024
2 min read

Updated: 6 days ago


Stylized illustration of a seated woman holding her lower back, with a dog in the foreground.


In the realms of pain management, the pursuit of innovative treatments that resonate with our body's intrinsic capacity for restoring function is unceasing. Today, I am thrilled to illuminate a significant stride in this quest, particularly for those grappling with the pervasive challenge of degenerative lumbar disc disease.


Special Notice on Study Parameters in Intradiscal OrthoBiologics


Intradiscal treatments are in general, not first line treatment for degenerative disc disease. Other criteria need to be observed and less invasive treatments should be considered first.


The average age in this study was 41.1 years.

Inclusion criteria from the study included refractory lower back pain persisting for 6 months or greater, failure of conservative treatment measures, maintained intervertebral disc height of at least 50%, disc protrusion less than 5 mm on imaging, concordant pain on discography, and presence of a grade 3 or grade 4 annular fissure.


Demystifying the Study's Insights


Consider the spine as the architectural backbone of our existence, intricately designed with vertebrae and intervertebral discs. These discs, vulnerable to the ravages of time, can deteriorate and precipitate a condition known as degenerative disc disease—often manifesting as relentless back pain.


In our discussion, we refer to the study conducted by Jennifer Cheng, Kristen A Santiago, Joseph T Nguyen, Jennifer L Solomon, and Gregory E Lutz, titled "Treatment of symptomatic degenerative intervertebral discs with autologous platelet-rich plasma: follow-up at 5–9 years."


This research offers significant insights into the long-term effectiveness of using autologous platelet-rich plasma in treating degenerative intervertebral disc conditions as a treatment for back pain .

The pivotal study has revisited patients who embraced a regenerative treatment modality: intradiscal platelet-rich plasma (PRP) injections. This approach harnesses the patient's own blood constituents to catalyze healing actions in the body. The outcomes are heartening—years down the line, a significant majority reported marked alleviation of pain and enhanced functional capacity, without the intervention of surgery.


For more information about this article, click here.


The Significance Unveiled


For both the patient and the physician, this information is more than mere statistical victories. Chronic back pain is not just a physical ailment; it is an affliction that can diminish the very essence of one's lifestyle and vitality. For practitioners, this opens a new chapter in treatment strategies that can potentially obviate the complexities and recuperative demands of surgical procedures in some cases.


Charting the Course to Restoration


This beacon of progress illuminates a path for those seeking solace from the persistent agony of back pain. PRP injections signify a sophisticated, minimally invasive recourse that leverages the regenerative potential of our own biological systems.


Invitation to a New Beginning


What unfolds before us is an opportunity—a possibility of eschewing more invasive paths in favor of a treatment that is in general, harmonious with our body's natural rhythms. I extend an invitation to explore this option, to engage in a dialogue about the potential of PRP in your journey toward recovery.

Let us embark on this path together, towards a future possibly unshackled from pain, a future where well-being and vitality could well be restored.


Stylized illustration of a smiling physician holding a small dog.

Comments


COSTS & COVERAGE

What will treatment cost?

Your evaluation is billed separately. Procedure costs depend on the treatment plan, so we provide an individualized estimate before scheduling.

​

​Orthobiologic procedures are generally not covered by traditional insurance. Regenexx employer benefits may cover eligible treatment, depending on your plan. CareCredit is available, subject to credit approval.

bottom of page